Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO WCGIC 2020 | Incidence of germline variants in young adults with NETs

Rachel Riechelmann • 6 Jul 2020
ESMO WCGIC 2020
Gastrointestinal Cancer Neuroendocrine Tumor

Rachel Riechelmann, MD, PhD, of the AC Camargo Cancer Canter, São Paulo, Brazil, discusses high incidence rate of pathogenic or likely pathogenic germline variants of cancer predisposing genes in young adults with neuroendocrine tumors (NETs). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Rachel Riechelmann

1:43
GASTHER2: trastuzumab for advanced gastric cancer
Rachel Riechelmann • 6 Jul 2020
1:58
Gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer
Rachel Riechelmann • 6 Jul 2020
2:33
Localized anal cancer in patients with HIV
Rachel Riechelmann • 6 Jul 2020

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals